Inventor · disambiguated record
Devin F. Welty
Also filed as: WELTY DEVIN F · WELTY DEVIN FRANKLIN · WELTY Devin
8 granted patents·23 pending applications·100 citations·filing 1993–2025
88Inventor score
Top patents by PatentIndex Score
31 records- 0196US8571802B2Method for determining optimum intraocular locations for drug delivery systemsROBINSON MICHAEL R·Filed 2007·Granted Oct 29, 2013·30 cites·5 claims
- 0294US7842714B2Ketorolac tromethamine compositions for treating ocular painALLERGAN INC·Filed 2009·Granted Nov 30, 2010·23 cites·3 claims
- 0389US8969415B2Intraocular drug delivery systemsROBINSON MICHAEL R·Filed 2006·Granted Mar 3, 2015·15 cites·2 claims
- 0487US2024197657A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2023·Application pending·0 cites
- 0583US9192571B2Ketorolac tromethamine compositions for treating or preventing ocular painFARNES ELDON Q·Filed 2009·Granted Nov 24, 2015·4 cites·26 claims
- 0681US2023181497A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2022·Application pending·0 cites
- 0779US2025000790A1Ketorolac compositions for corneal wound healingALLERGAN INC·Filed 2024·Application pending·0 cites
- 0875US2025281432A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2025·Application pending·0 cites
- 0972US2020197336A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2020·Application pending·0 cites
- 1066US2021315805A1Ketorolac compositions for corneal wound healingALLERGAN INC·Filed 2021·Application pending·0 cites
- 1163US2011046198A1Ketorolac tromethamine compositions for treating or preventing ocular painFARNES ELDON Q·Filed 2009·Application pending·0 cites
- 1261US5942513APharmaceutical composition and a method for treating neurodegenerative diseases using a combination of a kainate excitatory amino acid antagonist and an uricosuric agentWARNER LAMBERT CO·Filed 1998·Granted Aug 24, 1999·12 cites·10 claims
- 1361US5407935APharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistWARNER LAMBERT CO·Filed 1993·Granted Apr 18, 1995·10 cites·4 claims
- 1460US2012196914A1Ketorolac tromethamine compositions for treating or preventing ocular painFARNES ELDON QUINN·Filed 2012·Application pending·0 cites
- 1559US2011275688A1Ketorolac compositions for corneal wound healingALLERGAN INC·Filed 2011·Application pending·0 cites
- 1659US2010298205A1Methods and compositions for the treatment of conditions related to gastric acid secretionSHEN JIE·Filed 2009·Application pending·0 cites
- 1758US2011160271A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2010·Application pending·0 cites
- 1857US2016243078A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2015·Application pending·0 cites
- 1957US2013245088A1Ketorolac compositions for corneal wound healingHOLLANDER DAVID A·Filed 2011·Application pending·0 cites
- 2057US2009048302A1Methods and compositions for the treatment of conditions related to gastric acid secretionALLERGAN INC·Filed 2005·Application pending·0 cites
- 2156US2012196913A1Ketorolac tromethamine compositions for treating or preventing ocular painFARNES ELDON Q·Filed 2012·Application pending·0 cites
- 2255US2006241037A1Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugsALLERGAN INC·Filed 2004·Application pending·0 cites
- 2353US2006182781A1Methods for treating ocular conditions with cyclic lipid contraining microparticlesALLERGAN INC·Filed 2006·Application pending·0 cites
- 2452US2014010823A1Method for determining optimum intraocular locations for drug delivery systemsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2552US2014341968A1Intraocular Drug Delivery SystemsALLERGAN INC·Filed 2014·Application pending·0 cites
- 2647US2005075371A1Methods and compositions for the oral administration of prodrugs of proton pump inhibitorsALLERGAN INC·Filed 2004·Application pending·0 cites
- 2746US5627168APharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistWARNER LAMBERT CO·Filed 1995·Granted May 6, 1997·4 cites·4 claims
- 2843US2013030032A1Ketorolac tromethamine compositions for treating or preventing ocular painFARNES ELDON Q·Filed 2010·Application pending·0 cites
- 2939US5767119AMethod of treating neurodegenerative diseases using an AMPA excitatory amino and an uricosuric agentWARNER LAMBERT CO·Filed 1996·Granted Jun 16, 1998·2 cites·14 claims
- 3036US2020009130A1Ocular distribution and pharmacokinetics of lifitegrast formulationsSARCODE BIOSCIENCE INC·Filed 2017·Application pending·0 cites
- 3134US2011021595A1Ketorolac tromethamine compositions for treating or preventing ocular painALLERGAN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Devin F. Welty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →